AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2008

Apr 8, 2008

29831_dirs_2008-04-07_190c24f4-ceec-49b9-bb1f-8d45a7357d17.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ENCYSIVE PHARMACEUTICALS INC (ENCY)
CIK: 0000887023
Period of Report: 2008-04-01

Reporting Person: PFIZER INC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	61765295	Indirect

Footnotes

F1: Represents 61,765,295 shares purchased by tender offer by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer
Inc.

F2: Shares owned directly by Explorer Acquisition Corp., a wholly-owned subsidiary of Pfizer Inc.

F3: This amendment is made solely to correct the original Form 3 filed on April 3, 2008 by removing the 8,473,574 shares that had
been included in the amount of securities beneficially owned. Such shares were subject to guaranteed delivery procedures.